Abeona Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Abeona Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Abeona Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Abeona Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Abeona Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Abeona Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Vishwas Seshadri, Ph.D.
Chief Executive Officer; President; Director Executive BoardMr. Vishwas Seshadri has been the President, Chief Executive Officer, and Director of the company since 2021. Prior to this, he served at Celgene Corporation in roles of increasing responsibility focusing on the development and commercialization of novel therapies in oncology and hematology. Previously, he served as the Head of Early-Stage Upstream Process Development at Dr. Reddy's Laboratories.
Joseph Vazzano
Chief Financial Officer Senior ManagementMr. Joseph Vazzano has been the Chief Financial Officer of the company since 2022. Prior to this, he served as the Chief Financial Officer, Vice President of Finance and Corporate Controller at Avenue Therapeutics Inc. Previously, he served as the Assistant Corporate Controller at Intercept Pharmaceuticals Inc.
Brendan O’Malley, Ph.D.
General Counsel; Chief Legal Officer Senior ManagementMr Brendan O’Malley has been the General Counsel and Chief Legal Officer of the company since 2021. Prior to this, he served as the Chief IP Counsel of the company.
Brian Kevany, Ph.D.
Chief Scientific Officer; Senior ManagementMr Brian Kevany has been the Chief Technical Officer and Chief Scientific Officer since 2024. Prior to this, served as the Scientist, Product Development of the company. Previously, he served as the Senior Scientist at AgriPlex Genomics.
Mohamad Tabrizi
Senior Vice President; Chief Business Officer Senior ManagementMr. Mohamad Tabrizi has been the Senior Vice President and Chief Business Officer of the company since December 2025. Previously, he served as General Partner and Managing Director at Pandect Bioventures. Prior to this, he served as Chief Executive Officer of Azkarra Therapeutics. Prior to that, he worked at AstraZeneca, Bristol-Myers Squibb, Pfizer, Merck, and Amgen.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer